Mitral valve replacement after percutaneous transvenous mitral commissurotomy.
Percutaneous transvenous mitral commissurotomy is widely performed as the first choice of the non-pharmacological treatments for mitral stenosis. Five patients have been identified who required mitral valve replacement after percutaneous transvenous mitral commissurotomy. The causes leading to mitral valve replacement were mitral regurgitation in three cases and insufficient commissurotomy in two. Massive mitral regurgitation is one of the most serious complications of percutaneous transvenous mitral commissurotomy. This report aims to elucidate the mechanism of massive mitral regurgitation occurring during percutaneous transvenous mitral commissurotomy. In every such case, there was a large tear in the posterior leaflet without any split in the commissures. The Japanese literature reports that 16 patients have undergone mitral valve replacement for massive regurgitation after percutaneous transvenous mitral commissurotomy: 14 of these cases had a tear in one of the leaflets and no evidence of splitting of the posterior commissure. These facts indicate that relative fragility of the leaflets as compared with rigidity of commissural fusion, especially in the posterior commissure, is an important factor of massive mitral regurgitation during percutaneous transvenous mitral commissurotomy.
Kotsuka
Y
Y
Department of Cardiothoracic Surgery, University of Tokyo, Japan.
Furuse
A
A
Yagyu
K
K
Kawauchi
M
M
Takeda
M
M
Hirata
K
K
D000368:Aged; D005260:Female; D006350:Heart Valve Prosthesis; D006801:Humans; D008297:Male; D008875:Middle Aged; D008943:Mitral Valve / Q000473:pathology / Q000601:surgery*; D008944:Mitral Valve Insufficiency / Q000473:pathology / Q000601:surgery*; D008946:Mitral Valve Stenosis / Q000473:pathology / Q000601:surgery*; D010210:Papillary Muscles / Q000473:pathology; D011183:Postoperative Complications / Q000473:pathology / Q000601:surgery*; D012086:Reoperation; D012307:Risk Factors